The Biotech Growth Trust PLC (BIOG.L) Research
The Biotech Growth Trust PLC, a closed-ended equity investment vehicle, was originally established by Frostrow Capital LLP and is jointly managed by OrbiMed Capital LLC. Formed on May 20, 1997, and legally based in the United Kingdom, this trust allocates its capital to global public equity markets. Its primary objective is to invest in shares of companies operating within the biotechnology sector, spanning the full range of market capitalizations. The construction of its investment portfolio relies on rigorous fundamental analysis, and its performance is benchmarked against the NASDAQ Biotechnology Index. It was previously identified as Finsbury Emerging Biotechnology Trust PLC.
Market snapshot
- Symbol
- BIOG.L
- Price
- $1,384
- Day change
- +1.47%
- Market cap
- $267.3M
- P/E ratio
- 2.48x
- 52-week range
- 701.631-1469.19
- Sector
- Financial Services
- Industry
- Asset Management
Peer companies
- Albion Enterprise VCT PLC (AAEV.L)
- Albion Technology & General VCT PLC (AATG.L)
- AVI Japan Opportunity Trust PLC (AJOT.L)
- Baillie Gifford UK Growth Trust plc (BGUK.L)
- CT Global Managed Portfolio Growth Ord (CMPG.L)
- The Diverse Income Trust plc (DIVI.L)
- International Biotechnology Trust plc (IBT.L)
- Montanaro European Smaller Companies Trust plc (MTE.L)
Open The Biotech Growth Trust PLC (BIOG.L) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.